Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 3
Submit an article Journal homepage
765
Views
3
CrossRef citations to date
0
Altmetric
Research Paper

Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma

Xiaodong Wanga Department of Oncology, Zibo City Fourth People’s Hospital, Zibo, Shandong, ChinaView further author information
,
Xia Tiana Department of Oncology, Zibo City Fourth People’s Hospital, Zibo, Shandong, ChinaView further author information
,
Xufang Suib Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, ChinaView further author information
,
Xiangfeng Lic Department of Radiology, Zibo City Fourth People’s Hospital, Zibo, Shandong, ChinaView further author information
,
Xiaoyang Zhaod Department of Surgery, Zibo City Fourth People’s Hospital, Zibo, Shandong, ChinaView further author information
,
Kai Hane Department of Internal Medicine, Zibo City Fourth People’s Hospital, Zibo, Shandong, ChinaView further author information
,
Lingyan Sunf Department of Oncology, Zibo Central Hospital, Zibo, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Yujin Dongf Department of Oncology, Zibo Central Hospital, Zibo, ChinaView further author information
 show all
Pages 6113-6125 | Received 01 Oct 2021, Accepted 08 Dec 2021, Published online: 07 Mar 2022

References

  • Eberlein A, Takasuga A, Setoguchi K, et al. Dissection of genetic factors modulating fetal growth in cattle indicates a substantial role of the non-SMC condensin I complex, subunit G (NCAPG) gene. Genetics. 2009;183(3):951–964.
  • Sun DP, Lin CC, Hung ST, et al. Aberrant expression of NCAPG is associated with prognosis and progression of gastric cancer. Cancer Manag Res. 2020;12:7837–7846.
  • Wang Y, Gao B, Tan PY, et al. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth. FASEB J. 2019.
  • Xu T, Dong M, Wang Z, et al. Elevated mrna expression levels of ncapg are associated with poor prognosis in ovarian cancer. Cancer Manag Res. 2020.
  • Gong C, Ai J, Fan Y, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through PI3K/AKT signaling. Onco Targets Ther. 2019;12:8537–8552.
  • Zhang X, Wang H, Han Y, et al. NCAPG induces cell proliferation in cardia adenocarcinoma via PI3K/AKT signaling pathway. Onco Targets Ther. 2020;13:11315–11326.
  • Zhang X, Zhu M, and Wang H, et al. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway. Gene. 2021;766:145163.
  • Wei L, Sun J, and Zhang N, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):1–17.
  • Cao Y. Adipocyte and lipid metabolism in cancer drug resistance. J Clin Invest. 2019;129(8):3006–3017.
  • Panda M, Biswal BK. Cell signaling and cancer: a mechanistic insight into drug resistance. Mol Biol Rep. 2019;46(5):5645–5659.
  • Si W, Shen J, and Zheng H, et al. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin Epigenetics. 2019;11(1):1–24 .
  • An Y, Zhou L, Huang Z, et al. Molecular insights into cancer drug resistance from a proteomics perspective. Expert Rev Proteomics. 2019;16(5):413–429.
  • Jiang L, Ren L, Chen H, et al. NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer. Cell Death Dis. 2020;11(7). DOI:10.1038/s41419-020-02753-x.
  • Odell ID, Cook D. Immunofluorescence techniques. J Invest Dermatol [Internet]. 2013 cited 2021 Nov 6;133. Available from https://pubmed.ncbi.nlm.nih.gov/23299451/
  • Darzynkiewicz Z, Bedner E, Smolewski P. Flow cytometry in analysis of cell cycle and apoptosis. Semin Hematol [Internet]. 2001 [cited 2021 Nov 6];38(2):179–193. Available from https://pubmed.ncbi.nlm.nih.gov/11309699/
  • Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
  • Song B, Du J, Song DF, et al. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer. Biol Res. 2018;51(1). DOI:10.1186/s40659-018-0192-5
  • Yamamoto S, Takayama KI, Obinata D, et al. Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer. Cancer Sci. 2019;110(11):3476–3485.
  • Liu B, Xiao Y, and Li H, et al. Identification and verification of biomarker in clear cell renal cell carcinoma via bioinformatics and neural network model. Biomed Res Int. 2020;13(2):1–13.
  • Chen N, Zhang G, Fu J, et al. Identification of key modules and hub genes involved in esophageal squamous cell carcinoma tumorigenesis using WCGNA. Cancer Control. 2020;27(1):107327482097881.
  • Wang W. Exosome-derived mir-221-3p promotes angiogenesis by targeting THBS2 in cervical cancer. Int J Gynecol Obstet. 2018;22(3):397–410.
  • Chen MW, Yang ST, Chien MH, et al. The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer. Cancer Res. 2017;77(8):1955–1967.
  • Arai T, Okato A, Yamada Y, et al. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC. Cancer Med. 2018;7(5):1988–2002.
  • Ai J, Gong C, Wu J, et al. MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG. Cancer Manag Res. 2019;11:3455–3467.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.